These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 6047880)
21. The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR). Singleton DC; Li D; Bai SY; Syddall SP; Smaill JB; Shen Y; Denny WA; Wilson WR; Patterson AV Cancer Gene Ther; 2007 Dec; 14(12):953-67. PubMed ID: 17975564 [TBL] [Abstract][Full Text] [Related]
22. Bendamustine (Treanda) for CLL and NHL. Med Lett Drugs Ther; 2008 Nov; 50(1299):91-2. PubMed ID: 19008789 [No Abstract] [Full Text] [Related]
23. Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets. Tew KD; Erickson LC; White G; Wang AL; Schein PS; Hartley-Asp B Mol Pharmacol; 1983 Sep; 24(2):324-8. PubMed ID: 6888373 [TBL] [Abstract][Full Text] [Related]
24. Effect of cytostatics on the migration of leukocytes. Horváth M; Bakács T Oncology; 1982; 39(1):29-30. PubMed ID: 7058044 [TBL] [Abstract][Full Text] [Related]
25. Conversion of the Enzymatically Derived (1S,2S)-3-Bromocyclohexa-3,5-diene-1,2-diol into Enantiomerically Pure Compounds Embodying the Pentacyclic Framework of Vindoline. White LV; Banwell MG J Org Chem; 2016 Feb; 81(4):1617-26. PubMed ID: 26788805 [TBL] [Abstract][Full Text] [Related]
26. Taxoid from the needles of the Himalayan yew Taxus wallichiana with cytotoxic and immunomodulatory activities. Chattopadhyay SK; Pal A; Maulik PR; Kaur T; Garg A; Khanuja SP Bioorg Med Chem Lett; 2006 May; 16(9):2446-9. PubMed ID: 16480866 [TBL] [Abstract][Full Text] [Related]
27. THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS. JOHNSON IS; ARMSTRONG JG; GORMAN M; BURNETT JP Cancer Res; 1963 Sep; 23():1390-427. PubMed ID: 14070392 [No Abstract] [Full Text] [Related]
29. Mechnaism of action of anticancer drugs at a cellular level. Karnofsky DA CA Cancer J Clin; 1968; 18(4):232-4. PubMed ID: 4992875 [No Abstract] [Full Text] [Related]
30. Differences in cyclin B1 expression in cells blocked in the G2M phase after treatment with anticancer agent. New three-parametric flow cytometric analysis. Faretta M; Bergamaschi D; Ronzoni S; D'Incalci M; Erba E Eur J Histochem; 1997; 41 Suppl 2():73-4. PubMed ID: 9859790 [No Abstract] [Full Text] [Related]
31. Potential anticancer agents. XX. 1. Steric fit analysis in aromatic nitrogen mustards area. Bădilescu II; Crăescu T; Niculescu-Duvăz I; Simon Z Neoplasma; 1980; 27(3):261-9. PubMed ID: 7453846 [TBL] [Abstract][Full Text] [Related]
32. [Non-stathmokinetic cytotoxic activity of vinblastine and vincristine on primary cultures of human neoplasms]. Morasca L; Conventi L Cancro; 1968; 21():Suppl 6:14-24. PubMed ID: 5740703 [No Abstract] [Full Text] [Related]
33. Kinetics of micronucleated polychromatic erythrocyte (MN-PCE) induction in vivo by aneuploidogens. Morales-Ramírez P; Vallarino-Kelly T; Cruz-Vallejo V Mutat Res; 2004 Dec; 565(1):79-87. PubMed ID: 15576241 [TBL] [Abstract][Full Text] [Related]
34. [Ultrastructure changes in ameloblasts of rats administered with vincristine and vinblastine (author's transl)]. Sawada T Shikwa Gakuho; 1982 Mar; 82(3):347-83. PubMed ID: 6955956 [No Abstract] [Full Text] [Related]
35. [Mechanism of action of pafencil on sensitive and resistant tumor cells]. Ivanova LE; Kotel'nikov VM Gematol Transfuziol; 1992 Mar; 37(3):37-9. PubMed ID: 1516801 [No Abstract] [Full Text] [Related]
36. Effect of vinblastine, vincristine, and vindesine on neutrophil phagocytosis and iodination. Chohan V; Lowenthal RM Cancer Treat Rep; 1982 Mar; 66(3):505-8. PubMed ID: 7037181 [No Abstract] [Full Text] [Related]
37. Effects of vinblastine and vincristine on survival and hemopoiesis in irradiated mice. Smith WW; Wilson SM J Natl Cancer Inst; 1967 Nov; 39(5):1055-66. PubMed ID: 6066440 [No Abstract] [Full Text] [Related]
38. Antitubulin activity of vinblastine and vincristine. Clinical implications of the radial segmentation test. Simmingsköld G; Norberg B; Norberg A; Söderström UB Eur J Clin Pharmacol; 1981; 19(6):413-6. PubMed ID: 7250174 [TBL] [Abstract][Full Text] [Related]